@diefenbacherlab.bsky.social
Targeting protein stability in #Cancer via #Ubiquitin-System @HelmholtzMunich @LungHealthMUC and @LMU_Muenchen Impressum: http://www.diefenbacher-lab.com/Impressum/ http://www.diefenbacher-lab.com/ https://www.helmholtz-munich.de/en/environmental-health-ce
Getting ready to kick off our first Bridging Minds in #MunichCancerResearch #Workshop @bmc-lmu.bsky.social #LMU-Munich ! #Cancer is a devastating disease and the #collaboration and #exchange between #clinicians and #scientists is an important first step to lay the foundation for new #therapies.
12.03.2025 08:00 — 👍 11 🔁 4 💬 0 📌 0
Have a look at this exciting #collaborative #work by Amir Orian, Ashraf Brik Technion Haifa and @diefenbacherlab.bsky.social@www.helmholtz.de on #PROTAC like #degraders to deplete aggressive tumor cells! #ubiquitin and #degradation are indeed #promising #therapeutics www.biorxiv.org/content/10.1...
29.12.2024 15:43 — 👍 10 🔁 3 💬 0 📌 0
The 2025 EMBL Annual Poster, listing all of the courses and conferences taking place in 2025 at EMBL
Hi Bluesky community! 👋
Are you looking forward to 2025 as much as we are? 👀
We just updated our 2025 Annual Poster to include even more events for you to join, so go and have a look!
➡️ s.embl.org/poster-bl
#EMBLEvents #molecularbiology #lifesciencetraining
Exciting lecture about #lung #transplant at German Center for Lung Research @bmc-lmu.bsky.social @www.helmholtz.de research institute Lung Health and Immunity in Munich!
05.12.2024 10:09 — 👍 4 🔁 0 💬 0 📌 0
Leveraging Dual-Ligase Recruitment to Enhance Protein Degradation via a Heterotrivalent Proteolysis Targeting Chimera | Collaboration with @georgwinter.bsky.social and Kristin Riching labs. Now published in Journal of the American Chemical Society @acsjacs.bsky.social pubs.acs.org/doi/10.1021/...
30.11.2024 16:35 — 👍 55 🔁 13 💬 2 📌 1Promoting a positive research culture is so important to support each other - and to ultimately enable great science!
@colemanlab.bsky.social has put together an array of scientists who are striving for this in many different ways ⤵️
#research #culture 🧪
We have an open #PhD #studentship as part of our "Black Leaders in Cancer" programme at @crukconvergence.bsky.social & @icrlondon.bsky.social. About computational modelling of T-cell evolution in cancer. www.findaphd.com/phds/project... I'm looking forward to meeting prospective students #CRUKfunded
28.11.2024 09:40 — 👍 32 🔁 28 💬 0 📌 1
Attending the annual German Centres for Lung Research meeting with a focus on @cancer #frombenchtobed in Bad Nauheim. Exciting talks about ongoing clinical trials and screening efforts in Germany. Will follow up with a talk about our research on ubiquitin signalling in @lungcancer tomorrow!
28.11.2024 12:35 — 👍 3 🔁 0 💬 0 📌 0
Excited to report our discovery of an important component of the oxidative stress response: the E3 ligase TRIP12. It acts as a chain elongation factor that amplifies CUL3-KEAP1 activity to drive NRF2 degradation as cells recover from stress.
www.biorxiv.org/content/10.1...
Welcome to the Tumor Macroenvironment (yes, that's an "a", not a typo). I hope this is helpful for those interested in cancer as a systemic disease. So much to learn!
go.bsky.app/RQuYfnK
New week, updated starter pack. Now with 69 profiles to follow if you are interested in anything #ubiquitin or #Ubl: signalling, structure and biochemistry, biology, mechanisms, proteostasis, TPD, chemical biology, etc. Let me know if you or anyone else is missing.
25.11.2024 08:32 — 👍 21 🔁 15 💬 4 📌 1Check out this list of ubiquitin and Ubl profiles to follow. Repost if you want me to add you to it. Let’s create a good community here ☁️ go.bsky.app/3VPQofn
15.11.2024 19:38 — 👍 49 🔁 48 💬 6 📌 1
